Celloid

Private

PohangHealthcare & Life Scienceshttps://celloid.co.kr/

Last Round

Series A

Mar 12, 2026

Est. Valuation

$26.32M

Total Funding Raised

$6.77M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Celloid is a biotechnology company that develops and supplies three-dimensional (3D) cell culture automation systems and solutions for organoids and spheroids.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Advanced Materials, Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

organoid culture3d cell cultureautomated cell cultureorganoid manufacturinganimal testing alternativedrug discoveryregenerative medicinemini-organsCDMO servicesorganoidsdisease modelingspheroid culturebiotech equipmentprecision medicinecontract development and manufacturing organizationtoxicology studies

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Celloid Comps

Public and private peers based on sector, stage, and business model.

Celloid comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Celloid Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Mar 12, 2026
VC Round	Jan 31, 2024
Seed	Jun 1, 2022

View all Funding Rounds

Celloid Investors

Notable investors and investment history

Celloid investors
Investor	Rounds
POSTECH Holdings Co., Ltd.	VC Round, Seed
FuturePlay	VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 12, 2026
$7M round completed
Jan 31, 2024
$1.8M round led by POSTECH Holdings and FuturePlay.

View all signals

Celloid Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Celloid Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Celloid's valuation, stock price, and market status.

Firmographic Details

HeadquartersPohang

Year Founded2021

Last FundingMar 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.